May 14, 2020 / 1:35 PM / 22 days ago

BRIEF-Morphosys And Incyte Announce Follow-Up Results From Study Of Tafasitamab

May 14 (Reuters) - Morphosys AG:

* DGAP-NEWS: MORPHOSYS AND INCYTE ANNOUNCE LONG-TERM FOLLOW-UP RESULTS FROM L-MIND STUDY OF TAFASITAMAB IN PATIENTS WITH R/R DLBCL

* MORPHOSYS AG - FULL EFFICACY AND SAFETY DATA TO BE PRESENTED VIRTUALLY AT 25^TH EHA ANNUAL CONGRESS Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below